In this regard, the translational relevance of this preclinical study was demonstrated in patients with obesity by correlation of: (1) circulating FGF21 levels 4 weeks after mRYGB with the initial fat mass and one-year body weight reduction, (2) circulating FFAs with 4 week-body weight loss in mRYGB patients and (3) circulating adiponectin and OXM with weight loss
Who is a Good Candidate for Sermorelin Treatment
Many mammalian studies have shown that only l-carnitine has beneficial effects ( Reference Liedtke, Nellis and Whitesell 16 Reference Spasov, Iezhitsa and Pisarev 18 ) , while d-carnitine can interfere with the uptake and transport of l-carnitine ( Reference Vernez 13 , Reference Paulson and Shug 19 ) , and therefore inhibit the -oxidation of FA ( Reference Spasov and Iezhitsa 20 , Reference Leichter, Ottem and Hahn 21 ) , which has a hepatotoxic effect ( Reference Arafa 22 )
While this may not be applicable to all patients, for those who have achieved sufficient weight loss, gradually extending the injection interval is a promising strategy to reduce the burden while maintaining the effects, the research team stated
